Category Archives: People

BioVie Announces Full Enrollment of the ADDRESS-LC Trial of Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID

-Topline Data Release Targeted Late Summer 2026- CARSON CITY, Nev., May 26, 2026 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced full enrollment of the Company’s ADDRESS-LC Phase 2 trial evaluating its drug candidate bezisterim for the treatment […]

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

BOSTON, May 26, 2026 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that David Meeker, M.D., Chairman, President and Chief Executive Officer, and Hunter Smith, Chief Financial Officer, will participate in fireside chats at two upcoming […]

Nu-Tek BioSciences Fuels Animal-Free Raw Materials Revolution, Joins Minnesota Pavilion #4507 at BIO 2026

Nu-Tek BioSciences joins the MN DEED Minnesota Pavilion at BIO, June 22-25 in San Diego, CA, offering biotech innovators a blueprint for scalable, animal-free manufacturing through its product portfolio and Variability Reduction Program. MINNETONKA, Minn., May 26, 2026 (GLOBE NEWSWIRE) — As the global biotech community gathers for BIO International in June, Nu-Tek BioSciences is […]

Rani Therapeutics Holdings, Inc. Announces Pricing of $20.0 Million Registered Direct Offering of Class A Common Stock Priced At-The-Market Under Nasdaq Rules

SAN JOSE, Calif., May 26, 2026 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced that it has entered into a securities purchase agreement led by a sovereign wealth fund, along with other new and existing […]

MINILUXE REPORTS FIRST QUARTER FINANCIAL RESULTS FOR THE 13 WEEKS ENDED MARCH 29, 2026

Company Announces Strong Start to 2026 with +8% System Revenue Growth, +5% Gross Profit, Gross Margin Expansion to 42%, and SG&A Discipline in Q1 2026 All reported figures in U.S. Dollars unless otherwise noted Boston, MA, May 25, 2026 (GLOBE NEWSWIRE) — MiniLuxe Holding Corp. (TSXV: MNLX) today announced its financial results for the 13 […]

A Grand Success! The 2026 China Tourism Day Main Venue Debuts at Canton Tower – Witness the Transformation from a City Landmark to a National Stage

GUANGZHOU, China, May 26, 2026 (GLOBE NEWSWIRE) — On May 19, 2026, the 16th China Tourism Day was successfully held at the Guangzhou City Construction Investment Group’s Canton Tower Tourism Area. Since the event was established in 2011, this is the first time Guangzhou has served as the main host city for the event. A […]

AGC Biologics to Manufacture Teikoku Seiyaku’s rhMMP-7 Drug Substance

AGC Biologics to provide process development and GMP manufacturing for a novel therapy, leveraging its global microbial network across Germany and Japan. HEIDELBERG, Germany and CHIBA, Japan, May 26, 2026 (GLOBE NEWSWIRE) — AGC Biologics, your friendly CDMO expert, was selected by Teikoku Seiyaku Co., Ltd., a leader in transdermal drug delivery, to provide microbial […]

Hormify Customers Report 95% Support Satisfaction: How the Brand Is Setting a New Standard in Supplement Customer Care

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) — Customer support in the dietary supplement industry has long been a weak point. Consumer complaints filed with the Better Business Bureau and major review platforms consistently cite slow response times, unresolved billing disputes, and difficulty reaching a real person as the top post-purchase frustrations. For subscription-based supplement […]

No Hidden Enrollments, No Refund Runaround: How Hormify Is Raising the Bar for Supplement Billing

NEW YORK, May 26, 2026 (GLOBE NEWSWIRE) — The subscription wellness industry has a trust problem. Consumers across the United States are increasingly wary of health supplement brands that bury auto-enrollment terms in fine print, make cancellation deliberately difficult, and resist refund requests even when products go unused. According to the Federal Trade Commission, subscription […]

AB Science announces that its stock continues to be covered by Maxim Group, with a target price of €4.00 per share

PRESS RELEASE FOLLOWING RELEASE OF FYE2025 RESULTS AND SECURING OF CLINICAL TRIAL INSURANCE POLICY, MAXIM GROUP REITERATES ITS BUY RECOMMENDATION ON AB SCIENCE’S STOCK WITH A TARGET PRICE OF EUR 4.0 PER SHARE Paris, May 25, 2026, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) announces that its stock continues to be covered […]